SO
TVRD

STRS Ohio’s Tvardi Therapeutics TVRD Stock Holding History

STRS Ohio’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,356
Closed -$592K – 2335
2022
Q1 		$592K Sell
1,356
-475
-26% -$195K ﹤0.01% 1372
2021
Q4 		$802K Buy
1,831
+264
+17% +$133K ﹤0.01% 1269
2021
Q3 		$871K Sell
1,567
-116
-7% -$58.2K ﹤0.01% 1196
2021
Q2 		$864K Buy
1,683
+1,622
+2,659% +$1.03M ﹤0.01% 1260
2021
Q1 		$47K Buy
+61
New +$41.8K ﹤0.01% 2039
2014
Q4 		– Sell
-142
Closed -$43K – 1815
2014
Q3 		$43K Buy
+142
New +$58.3K ﹤0.01% 1666

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STRS Ohio's TVRD Position: Q2 2022 in Review

STRS Ohio sold out of Tvardi Therapeutics (TVRD) in Q2 2022, closing a stake of 1,356 shares — an estimated $592K sold.

STRS Ohio first reported a position in TVRD in Q3 2014 and held it in 6 quarters. The position peaked at $871K in Q3 2021. 178 funds tracked by Wall St. Rank hold TVRD as of Q2 2022.

  • STRS Ohio reported no remaining Tvardi Therapeutics position as of Q2 2022 after selling out during the quarter.
  • STRS Ohio sold 1,356 Tvardi Therapeutics shares in Q2 2022, an estimated $592K.
  • STRS Ohio first reported a position in Tvardi Therapeutics in Q3 2014 and held it in 6 quarters.
  • STRS Ohio's Tvardi Therapeutics position peaked at $871K in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.